-
effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/consumer
-
effectivehealthcare.ahrq.gov/products/infantile-hemangioma/consumer
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
June 01, 2015 - treatment sounds promising, but there are
still questions about how frequently a patient would need to be treated
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Of the 595 subjects, 173 subjects were treated in Phase 3 SBS
studies (134/173 [77%] at the dose of … The most commonly reported (≥10%) adverse reactions in patients treated…across all
clinical studies … After 24
weeks of treatment, 53.8% of patients treated with teduglutide reduced the number of infusion … days
per week by 1 or more days, compared with 23.1% of patients treated with placebo experiencing … Anemia may be treated with vitamin B12, folic acid, and increased dietary iron.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
January 01, 2011 - testing should be carried out annually in all patients with CKD and
that such patients should be treated … regimen (i.e., repletion or continuous treatment)
Interactions between treatments (i.e., patients treated … with vs. without ESAs, patients
treated with vs. without iron-replacement therapy)
Other factors … It is
commonly seen among ESA-treated patients due to the inability of transferrin-bound iron
to … The quality of life of hemodialysis recipients treated with
recombinant human erythropoietin.
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - with liraglutide 3 mg at 56 weeks was
8.0% compared to 2.6% for people treated with placebo. … At 56
weeks, 69% of the prediabetes subgroup treated with liraglutide 3 mg no longer
showed signs … of prediabetes, compared to 33% for the placebo-treated group. … Of the
39% of the people without prediabetes at randomisation, 7% of the liraglutide 3 mg
treated … They
were treated with metformin or a sulfonylurea drug or both.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - For patients with non–muscle-invasive
bladder cancer treated with transurethral resection of
bladder … In surveillance of patients treated
for non–muscle-invasive bladder cancer, what is the
effectiveness … For initial diagnosis or surveillance of
patients treated for non–muscle-invasive bladder cancer,
what … For patients with non–
muscle-invasive bladder cancer treated with
transurethral resection of bladder … For patients with non–
muscle-invasive bladder cancer treated with
transurethral resection of bladder
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - with liraglutide 3 mg at 56 weeks was
8.0% compared to 2.6% for people treated with placebo. … At 56
weeks, 69% of the prediabetes subgroup treated with liraglutide 3 mg no longer
showed signs … of prediabetes, compared to 33% for the placebo-treated group. … Of the
39% of the people without prediabetes at randomisation, 7% of the liraglutide 3 mg
treated … They were treated with
metformin or a sulfonylurea drug or both.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - The
median CRP of the treated patients was
12.0 (3.3-76.6).22
A study of tocilizumab found
improvement … Delayed clinical response in patients with
juvenile idiopathic arthritis treated with
etanercept. … Development of inflammatory bowel
disease in patients with juvenile idiopathic
arthritis treated with … The
median CRP of the treated
patients was 12.0 (3.3-76.6)
Key Question 1b: Improve radiological … At the
end of the 6 month withdrawal
period (B) abatacept-treated
subjects had greater
improvements
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - The
median CRP of the treated patients was
12.0 (3.3-76.6).22
A study of tocilizumab found
improvement … Delayed clinical response in patients with
juvenile idiopathic arthritis treated with
etanercept. … Development of inflammatory bowel
disease in patients with juvenile idiopathic
arthritis treated with … The
median CRP of the treated
patients was 12.0 (3.3-76.6)
Key Question 1b: Improve radiological … At the
end of the 6 month withdrawal
period (B) abatacept-treated
subjects had greater
improvements
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
March 01, 2019 - insufficient studies
b This cohort study had a median of 364 days on treatment although whether patients were treated … Comparison of the
tolerability and efficacy of citalopram and amitriptyline
in elderly depressed patients treated … treatment persistence, hospital utilization and costs
among major depressive disorder geriatric patients
treated … Assessment of falls
in older patients treated with duloxetine: a secondary
analysis of a 24-week randomized
-
effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
July 23, 2012 - undergo
surgery:
“When you see the
people
around you falling apart, you sort of have to get treated … differently, and so do many other men who have been treated
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - Only a fraction of treated patients respond within a week
of starting any of the many medications available … patients might be associated with reduced societal costs and improved
function and productivity of the treated … Department of Veterans Affairs, acute depressive episodes of bipolar
disorder are treated with combinations … also
sometimes considered.41 According to the National Institute of Mental Health, MDD is usually
treated … How is depression diagnosed and treated?
[internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
February 01, 2013 - (Which patients do equally well when treated nonoperatively or
operatively?) … Feb patients treated for rotator cuff disease. J Shoulder Elbow Surg. 2011;39(2):258-265. … (Which
patients do equally well when treated nonoperatively or operatively?) … Clinicians need to know what is being treated before choosing or comparing
treatments. … (Which patients do equally well when treated nonoperatively or
operatively?)
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - Authors reported the following:6,7
Patients treated with [Qsymia] had significant, sustained weight … with liraglutide 3 mg at 56 weeks was
8.0% compared to 2.6% for people treated with placebo. … At 56
weeks, 69% of the prediabetes subgroup treated with liraglutide 3 mg no longer
showed signs … of prediabetes, compared to 33% for the placebo-treated group. … They were treated with metformin or a sulfonylurea drug or
both.
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
January 01, 2012 - forced expiratory volume in 1 second measurement
that was 10.6 percentage points higher than patients treated … Patients treated with ivacaftor also demonstrated a significant improvement in quality of life
(p<0.001 … By 48 weeks, patients treated with ivacaftor had gained significantly more weight and
secreted significantly
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
October 01, 2011 - If > 6 yrs old are always treated with drugs, say so. … Peer Reviewer
#7
Results p 123 L-5 what does treated prevalence refer to? … As above
Peer Reviewer
#7
Results p 127 L-9 Does prevalence refer to treated (dx’d) prevalence? … Or extent to which it is treated? … Also, prevalence of medication use should be separate from
treated diagnostic prevalence.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
October 01, 2010 - How is it being used, and what is the evidence of benefits and harms for treated patients?
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
December 01, 2015 - systems could increase treatment rates and reduce health care
burdens typically associated with poorly treated … or under-treated PTSD. … increases might be offset by reduced burdens associated with managing previously ineffectively
treated … duty soldier with acute stress disorder, deployed at a
remote combat outpost, who was successfully treated … A comparison of mental health diagnoses treated
via interactive video and face to face in the
Veterans
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - It is estimated that fewer than 1 in 10
people who are treated for AUD receive medications.† Expanding